Medtronic, Inc
Products
Full Paper
Price: £95.00
Description: The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Published Date: 21/02/2012
Category: Drug Delivery & Devices
Research Report Decription
Medtronic,
Inc. - SWOT, Strategy and Corporate Finance Report, is a source of
comprehensive company data and information. The report covers the company’s
structure, operation, SWOT analysis, product and service offerings, detailed
financials, and corporate actions, providing a 360˚ view of the company.
Features:
- Provides all the crucial information on Medtronic, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Medtronic, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Medtronic, Inc.
- Data is supplemented with details on Medtronic, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Medtronic, Inc
Key Questions Answered:
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Companies Mentioned:
Medtronic, Inc
Paper Highlights:
Medtronic is a medical technology company engaged in manufacturing a range of medical devices and therapies. It has operations in more than 120 countries. Medtronic is headquartered in Minneapolis, Minnesota and employed about 45,000 people as of April 2011. The company recorded revenues of $15,933 million during the financial year ended April 2011 (FY2011), an increase of 0.7% over FY2010. The operating profit of the company was $4,001 million during FY2011, a decrease of 5.1% compared with FY2010. The net profit was $3,096 million in FY2011, a decrease of 0.1% compared with FY2010.